Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Current Leases (2023 - 2024)

Neuroone Medical Technologies (NMTC) has disclosed Current Leases for 2 consecutive years, with $65768.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Current Leases fell 49.06% year-over-year to $65768.0, compared with a TTM value of $65768.0 through Sep 2024, down 49.06%, and an annual FY2024 reading of $65768.0, down 49.06% over the prior year.
  • Current Leases was $65768.0 for Q3 2024 at Neuroone Medical Technologies, down from $129116.0 in the prior quarter.
  • Across five years, Current Leases topped out at $129116.0 in Q3 2023 and bottomed at $65768.0 in Q3 2024.